Baxter EBITDA 2010-2024 | BAX
Baxter annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Baxter EBITDA for the quarter ending March 31, 2024 was $0.522B, a 18.1% increase year-over-year.
- Baxter EBITDA for the twelve months ending March 31, 2024 was $1.810B, a 17.43% decline year-over-year.
- Baxter 2023 annual EBITDA was $1.73B, a 24.55% decline from 2022.
- Baxter 2022 annual EBITDA was $2.293B, a 3.43% increase from 2021.
- Baxter 2021 annual EBITDA was $2.217B, a 9.73% decline from 2020.
| Baxter Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $1,730 |
| 2022 | $2,293 |
| 2021 | $2,217 |
| 2020 | $2,456 |
| 2019 | $2,592 |
| 2018 | $2,355 |
| 2017 | $2,038 |
| 2016 | $1,545 |
| 2015 | $1,208 |
| 2014 | $1,448 |
| 2013 | $1,131 |
| 2012 | $3,482 |
| 2011 | $3,616 |
| 2010 | $2,821 |
| 2009 | $3,515 |
| Baxter Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $522 |
| 2023-12-31 | $653 |
| 2023-09-30 | $337 |
| 2023-06-30 | $298 |
| 2023-03-31 | $442 |
| 2022-12-31 | $575 |
| 2022-09-30 | $568 |
| 2022-06-30 | $607 |
| 2022-03-31 | $543 |
| 2021-12-31 | $245 |
| 2021-09-30 | $719 |
| 2021-06-30 | $646 |
| 2021-03-31 | $607 |
| 2020-12-31 | $619 |
| 2020-09-30 | $679 |
| 2020-06-30 | $550 |
| 2020-03-31 | $608 |
| 2019-12-31 | $745 |
| 2019-09-30 | $698 |
| 2019-06-30 | $574 |
| 2019-03-31 | $575 |
| 2018-12-31 | $571 |
| 2018-09-30 | $581 |
| 2018-06-30 | $579 |
| 2018-03-31 | $624 |
| 2017-12-31 | $476 |
| 2017-09-30 | $484 |
| 2017-06-30 | $531 |
| 2017-03-31 | $547 |
| 2016-12-31 | $504 |
| 2016-09-30 | $390 |
| 2016-06-30 | $274 |
| 2016-03-31 | $377 |
| 2015-12-31 | $344 |
| 2015-09-30 | $308 |
| 2015-06-30 | $277 |
| 2015-03-31 | $279 |
| 2014-12-31 | $391 |
| 2014-09-30 | $320 |
| 2014-06-30 | $912 |
| 2014-03-31 | $908 |
| 2013-12-31 | $608 |
| 2013-09-30 | $861 |
| 2013-06-30 | $1,011 |
| 2013-03-31 | $898 |
| 2012-12-31 | $701 |
| 2012-09-30 | $956 |
| 2012-06-30 | $957 |
| 2012-03-31 | $868 |
| 2011-12-31 | $792 |
| 2011-09-30 | $921 |
| 2011-06-30 | $1,000 |
| 2011-03-31 | $903 |
| 2010-12-31 | $702 |
| 2010-09-30 | $953 |
| 2010-06-30 | $867 |
| 2010-03-31 | $299 |
| 2009-12-31 | $905 |
| 2009-09-30 | $896 |
| 2009-06-30 | $901 |
| 2009-03-31 | $813 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $17.423B | $14.813B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.183B | 23.99 |
| Stryker (SYK) | United States | $129.169B | 30.94 |
| Boston Scientific (BSX) | United States | $112.541B | 35.85 |
| Medtronic (MDT) | Ireland | $103.915B | 15.56 |
| EssilorLuxottica (ESLOY) | France | $102.324B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.451B | 0.00 |
| Haleon (HLN) | United Kingdom | $39.452B | 28.80 |
| ResMed (RMD) | United States | $26.766B | 25.13 |
| Terumo (TRUMY) | Japan | $24.090B | 34.02 |
| Koninklijke Philips (PHG) | Netherlands | $23.739B | 18.84 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.313B | 14.25 |
| Insulet (PODD) | United States | $14.284B | 63.33 |
| Demant (WILYY) | Denmark | $10.984B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.977B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.098B | 26.48 |
| BellRing Brands (BRBR) | United States | $7.479B | 35.18 |
| Lantheus Holdings (LNTH) | United States | $5.472B | 13.64 |
| GN Store Nord (GNNDY) | Denmark | $4.529B | 25.43 |
| Haemonetics (HAE) | United States | $4.368B | 21.54 |
| Neogen (NEOG) | United States | $3.591B | 34.54 |
| Perrigo (PRGO) | Ireland | $3.561B | 10.79 |
| Prestige Consumer Healthcare (PBH) | United States | $3.418B | 16.27 |
| Envista Holdings (NVST) | United States | $2.910B | 12.01 |
| TG Therapeutics (TGTX) | United States | $2.845B | 80.04 |
| ICU Medical (ICUI) | United States | $2.837B | 25.04 |
| Green Thumb Industries (GTBIF) | United States | $2.671B | 52.29 |
| Agios Pharmaceuticals (AGIO) | United States | $2.568B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.271B | 12.61 |
| LeMaitre Vascular (LMAT) | United States | $1.800B | 52.76 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.781B | 0.00 |
| Warby Parker (WRBY) | United States | $1.539B | 0.00 |
| InMode (INMD) | Israel | $1.514B | 8.05 |
| AdaptHealth (AHCO) | United States | $1.353B | 10.06 |
| Verano Holdings (VRNOF) | United States | $1.275B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 10.78 |
| AtriCure (ATRC) | United States | $1.048B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.015B | 32.30 |
| BioLife Solutions (BLFS) | United States | $0.991B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.820B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.705B | 15.01 |
| Evolus (EOLS) | United States | $0.658B | 0.00 |
| PetIQ (PETQ) | United States | $0.647B | 20.92 |
| Surmodics (SRDX) | United States | $0.598B | 37.46 |
| VAREX IMAGING (VREX) | United States | $0.589B | 13.86 |
| Valneva SE (VALN) | France | $0.544B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.525B | 0.00 |
| Quanterix (QTRX) | United States | $0.490B | 0.00 |
| Jin Medical (ZJYL) | China | $0.457B | 0.00 |
| Biote (BTMD) | United States | $0.456B | 10.50 |
| TerrAscend (TSNDF) | Canada | $0.434B | 0.00 |
| ZimVie (ZIMV) | United States | $0.404B | 34.40 |
| OraSure Technologies (OSUR) | United States | $0.317B | 10.19 |
| Cerus (CERS) | United States | $0.312B | 0.00 |
| MacroGenics (MGNX) | United States | $0.282B | 0.00 |
| Zynex (ZYXI) | United States | $0.278B | 38.00 |
| Aurora Cannabis (ACB) | Canada | $0.278B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.254B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.250B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.248B | 24.61 |
| Omeros (OMER) | United States | $0.237B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.235B | 14.79 |
| High Tide (HITI) | Canada | $0.183B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.158B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.152B | 73.00 |
| FitLife Brands (FTLF) | United States | $0.151B | 21.43 |
| Quipt Home Medical (QIPT) | United States | $0.132B | 0.00 |
| Veru (VERU) | United States | $0.125B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Brainsway (BWAY) | Israel | $0.107B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 9.74 |
| InterCure (INCR) | Israel | $0.094B | 15.92 |
| Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| MariMed (MRMD) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.80 |
| Bright Green (BGXX) | United States | $0.056B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.056B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.018B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |